[HTML][HTML] HTLV-1 infection: An emerging risk. Pathogenesis, epidemiology, diagnosis and associated diseases
E Eusebio-Ponce, E Anguita… - Revista Española de …, 2019 - ncbi.nlm.nih.gov
ABSTRACT The Human T-Lymphotropic Virus type 1 (HTLV-1) affects up to 10 million
people worldwide. It is directly associated to one of the most aggressive T cell malignancies …
people worldwide. It is directly associated to one of the most aggressive T cell malignancies …
Mother-to-child HTLV-1 transmission: unmet research needs
C Rosadas, GP Taylor - Frontiers in microbiology, 2019 - frontiersin.org
Mother-to-child transmission (MTCT) of Human T-cell lymphotropic virus type 1 (HTLV-1)
causes lifelong infection. At least 5–10 million individuals worldwide are currently living with …
causes lifelong infection. At least 5–10 million individuals worldwide are currently living with …
Breastfeeding and the risk of infant illness in Asia: a review
Infancy remains the most vulnerable period of human life for death, illness, and establishing
a lifetime trajectory of growth and health. It is estimated that there are 5.3 million deaths …
a lifetime trajectory of growth and health. It is estimated that there are 5.3 million deaths …
Transactivation of human endogenous retroviruses by tumor viruses and their functions in virus-associated malignancies
Human endogenous retroviruses (HERVs), viral-associated sequences, are normal
components of the human genome and account for 8–9% of our genome. These original …
components of the human genome and account for 8–9% of our genome. These original …
Cabotegravir, the Long-Acting Integrase Strand Transfer Inhibitor, Potently Inhibits Human T-Cell Lymphotropic Virus Type 1 Transmission in vitro
BS Schneiderman, MS Barski, GN Maertens - Frontiers in Medicine, 2022 - frontiersin.org
Human T-cell lymphotropic virus type 1 (HTLV-1) is a deltaretrovirus most prevalent in
southwestern Japan, sub-Saharan Africa, Australia, South America, and the Caribbean …
southwestern Japan, sub-Saharan Africa, Australia, South America, and the Caribbean …
Antiretroviral therapy in HTLV-1 infection: an updated overview
The human T cell leukemic/lymphotropic virus type 1 (HTLV-1), discovered several years
ago, is the causative agent for a rapid progressive haematological malignancy, adult T cell …
ago, is the causative agent for a rapid progressive haematological malignancy, adult T cell …
Use of stem cell extracellular vesicles as a “holistic” approach to CNS repair
H Branscome, S Paul, D Yin, N El-Hage… - Frontiers in Cell and …, 2020 - frontiersin.org
Neurodegeneration is a hallmark of many diseases and disorders of the central nervous
system (CNS). High levels of neuroinflammation are often associated with irreparable …
system (CNS). High levels of neuroinflammation are often associated with irreparable …
Inhibition of HTLV-1 infection by HIV-1 first-and second-generation integrase strand transfer inhibitors
MS Barski, JJ Minnell, GN Maertens - Frontiers in Microbiology, 2019 - frontiersin.org
More than 10 million people worldwide are infected with the retrovirus human T-cell
lymphotropic virus type 1 (HTLV-1). Infection phenotypes can range from asymptomatic to …
lymphotropic virus type 1 (HTLV-1). Infection phenotypes can range from asymptomatic to …
Regulation of Expression and Latency in BLV and HTLV
A Pluta, JP Jaworski, RN Douville - Viruses, 2020 - mdpi.com
Human T-lymphotrophic virus type 1 (HTLV-1) and Bovine leukemia virus (BLV) belong to
the Deltaretrovirus genus. HTLV-1 is the etiologic agent of the highly aggressive and …
the Deltaretrovirus genus. HTLV-1 is the etiologic agent of the highly aggressive and …
HTLV-1 transmission and HIV pre-exposure prophylaxis: a scoping review
D Bradshaw, GP Taylor - Frontiers in Medicine, 2022 - frontiersin.org
HIV pre-exposure prophylaxis (HIV-PrEP) is effective in reducing the likelihood of HIV
acquisition in HIV-negative people at high risk of exposure. Guidelines recommend testing …
acquisition in HIV-negative people at high risk of exposure. Guidelines recommend testing …